Medicare Adopted New Cancer Screening Law
The new legislation creates a pathway for Medicare to cover multi-cancer early detection tests once they receive federal approval.
Updated on Sept. 24, 2026 in Cancer
Live Poll
Should the government prioritize expanding Medicare coverage for early-stage cancer detection screenings?
The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act was signed into law in February 2026. This legislation establishes a vital pathway for Medicare beneficiaries to access future multi-cancer early detection screenings.
Why it matters
Prior to this law, approximately 70 percent of cancer deaths were attributed to cancers that lacked covered screening tests. Ensuring Medicare access for new detection methods aims to improve early diagnosis and patient treatment outcomes.
A 2026 government statistic indicates that 70 percent of cancer deaths were caused by cancers without covered screening tests. This legislative shift provides a framework to integrate new detection technologies as they pass regulatory hurdles.
The players
Mike Crapo
A U.S. Senator representing Idaho who was recognized by the American Cancer Society Cancer Action Network and the American Association for Cancer Research.
American Cancer Society Cancer Action Network
The advocacy affiliate of the American Cancer Society that focuses on legislative solutions to cancer prevention, early detection, and treatment.
American Association for Cancer Research
A scientific organization that tracks cancer research developments and publishes progress reports to inform clinical and policy standards.
The details
The law authorizes the coverage of multi-cancer early detection screenings under Medicare once the U.S. Food and Drug Administration grants them approval. This mechanism intends to bridge the gap in diagnostic access, allowing beneficiaries to utilize blood-based or other emerging testing platforms to identify malignancies at earlier, more treatable stages.
Timeline
The EARLY Act was previously authorized in 2021.
The Medicare Multi-Cancer Early Detection Screening Coverage Act became law in February 2026.
The Senate Health, Education, Labor and Pensions Committee advanced EARLY Act reauthorization in June 2026.
The American Association for Cancer Research released the 2026 Cancer Progress Report in 2026.
The proposed reauthorization for the EARLY Act extends coverage through 2031.
Health Landscape
The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act represents a fundamental shift in how Medicare incorporates evolving diagnostic technologies. It follows a historical pattern of adapting coverage to include advancements in precision medicine and early detection.
This legislation establishes that Medicare coverage for new screening tests is contingent upon FDA approval rather than prior legislative action. If you are a Medicare beneficiary, discuss with your doctor how these forthcoming diagnostic tools may fit into your regular cancer screening schedule.
The takeaway
The new law creates a clear pathway for Medicare to cover multi-cancer screening once these tests are validated by the FDA. Patients should keep an eye on federal announcements regarding approved tests and consult their physician about appropriate screening timelines for their specific health history.
What happens next
The Breast Cancer Education and Awareness Requires Learning Young Act is currently being considered for reauthorization through 2031 following committee advancement in June 2026.
Further reading
For more information on the latest diagnostics and treatment standards, visit Cancer.
Source note: This article includes information reported by U.S. Senate Finance Committee.
Live Poll
Should the government prioritize expanding Medicare coverage for early-stage cancer detection screenings?
